Drug use in renal failure.

Autor: Haney SL

Publikováno v: Critical Care Nursing Clinics of North America; 2002 Mar, Vol. 14 Issue 1, p77-80, 4p

Development and Validation of an LC-MS/MS Assay for the Quantitation of MO-OH-Nap Tropolone in Mouse Plasma: Application to In Vitro and In Vivo Pharmacokinetic Studies.

Autor: Aldhafiri WN; Department of Pharmacy Practice and Science, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68198, USA., Chhonker YS; Department of Pharmacy Practice and Science, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68198, USA., Ahmed N; Department of Pharmacy Practice and Science, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68198, USA., Singh SK; Department of Pharmacy Practice and Science, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68198, USA., Haney SL; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA., Ford JB; Department of Pediatrics, University of Utah, Salt Lake City, UT 84113, USA., Holstein SA; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA., Murry DJ; Department of Pharmacy Practice and Science, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68198, USA.

Publikováno v: Molecules (Basel, Switzerland) [Molecules] 2024 Sep 18; Vol. 29 (18). Date of Electronic Publication: 2024 Sep 18.

Evaluation of geranylgeranyl diphosphate synthase inhibition as a novel strategy for the treatment of osteosarcoma and Ewing sarcoma.

Autor: Haney SL; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA., Feng D; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA., Chhonker YS; Department of Pharmacy Practice and Science, University of Nebraska Medical Center, Omaha, Nebraska, USA., Varney ML; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA., Williams JT; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA., Smith LM; Department of Biostatistics, University of Nebraska Medical Center, Omaha, Nebraska, USA., Ford JB; Department of Pediatrics, University of Nebraska Medical Center, Omaha, Nebraska, USA., Murry DJ; Department of Pharmacy Practice and Science, University of Nebraska Medical Center, Omaha, Nebraska, USA., Holstein SA; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.

Publikováno v: Drug development research [Drug Dev Res] 2023 Feb; Vol. 84 (1), pp. 62-74. Date of Electronic Publication: 2022 Nov 25.

The Peptide-Drug Conjugate Melflufen Modulates the Unfolded Protein Response of Multiple Myeloma and Amyloidogenic Plasma Cells and Induces Cell Death.

Autor: Flanagan K; Oncopeptides AB, Stockholm, Sweden., Kumari R; Institute for Molecular Medicine Finland - FIMM, HiLIFE - Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Finland., Miettinen JJ; Institute for Molecular Medicine Finland - FIMM, HiLIFE - Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Finland., Haney SL; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA., Varney ML; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA., Williams JT; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA., Majumder MM; Institute for Molecular Medicine Finland - FIMM, HiLIFE - Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Finland., Suvela M; Institute for Molecular Medicine Finland - FIMM, HiLIFE - Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Finland., Slipicevic A; Oncopeptides AB, Stockholm, Sweden., Lehmann F; Oncopeptides AB, Stockholm, Sweden., Nupponen NN; Oncopeptides AB, Stockholm, Sweden., Holstein SA; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA., Heckman CA; Institute for Molecular Medicine Finland - FIMM, HiLIFE - Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Finland.

Publikováno v: HemaSphere [Hemasphere] 2022 Feb 25; Vol. 6 (3), pp. e687. Date of Electronic Publication: 2022 Feb 25 (Print Publication: 2022).

In vivo evaluation of combination therapy targeting the isoprenoid biosynthetic pathway.

Autor: Haney SL; Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA., Varney ML; Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA., Chhonker Y; Department of Pharmacy Practice and Science, University of Nebraska Medical Center, Omaha, NE 68198, USA., Talmon G; Department of Pathology & Microbiology, University of Nebraska Medical Center, Omaha, NE 68198, USA., Smith LM; College of Public Health, University of Nebraska Medical Center, Omaha, NE 68198, USA., Murry DJ; Department of Pharmacy Practice and Science, University of Nebraska Medical Center, Omaha, NE 68198, USA; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, USA., Holstein SA; Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, USA. Electronic address: sarah.holstein@unmc.edu.

Publikováno v: Pharmacological research [Pharmacol Res] 2021 May; Vol. 167, pp. 105528. Date of Electronic Publication: 2021 Mar 03.